The British drug maker GlaxoSmithKline will no longer pay doctors to promote its products and will stop tying compensation of sales representatives to the number of prescriptions doctors write, its chief executive said Monday. Jerry Avorn, professor of medicine at Brigham and Women’s Hospital, is quoted.
